Year |
Citation |
Score |
2020 |
Tabachnick-Cherny S, Pinto S, Berko D, Curato C, Wolf Y, Porat Z, Karmona R, Tirosh B, Jung S, Navon A. Polyglutamine-Related Aggregates Can Serve as a Potent Antigen Source for Cross-Presentation by Dendritic Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 33067378 DOI: 10.4049/jimmunol.1901535 |
0.555 |
|
2017 |
Demishtein A, Fraiberg M, Berko D, Tirosh B, Elazar Z, Navon A. SQSTM1/p62-mediated autophagy compensates for loss of proteasome polyubiquitin recruiting capacity. Autophagy. 0. PMID 28792301 DOI: 10.1080/15548627.2017.1356549 |
0.586 |
|
2014 |
Berko D, Herkon O, Braunstein I, Isakov E, David Y, Ziv T, Navon A, Stanhill A. Inherent asymmetry in the 26S proteasome is defined by the ubiquitin receptor RPN13. The Journal of Biological Chemistry. 289: 5609-18. PMID 24429290 DOI: 10.1074/Jbc.M113.509380 |
0.496 |
|
2012 |
Berko D, Tabachnick-Cherny S, Shental-Bechor D, Cascio P, Mioletti S, Levy Y, Admon A, Ziv T, Tirosh B, Goldberg AL, Navon A. The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini. Molecular Cell. 48: 601-11. PMID 23041283 DOI: 10.1016/J.Molcel.2012.08.029 |
0.566 |
|
2006 |
Margalit A, Sheikhet HM, Carmi Y, Berko D, Tzehoval E, Eisenbach L, Gross G. Induction of antitumor immunity by CTL epitopes genetically linked to membrane-anchored beta2-microglobulin. Journal of Immunology (Baltimore, Md. : 1950). 176: 217-24. PMID 16365413 DOI: 10.4049/Jimmunol.176.1.217 |
0.341 |
|
2005 |
Berko D, Carmi Y, Cafri G, Ben-Zaken S, Sheikhet HM, Tzehoval E, Eisenbach L, Margalit A, Gross G. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 174: 2116-23. PMID 15699142 DOI: 10.4049/Jimmunol.174.4.2116 |
0.368 |
|
2003 |
Margalit A, Fishman S, Berko D, Engberg J, Gross G. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells. International Immunology. 15: 1379-87. PMID 14565936 DOI: 10.1093/Intimm/Dxg136 |
0.332 |
|
Show low-probability matches. |